Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Annals of Oncology Année : 2019

Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases

Résumé

Challenges in obtaining tissue specimens from patients with brain tumours limit the diagnosis and molecular characterisation and impair the development of better therapeutic approaches. The analysis of cell-free tumour DNA in plasma (considered a liquid biopsy) has facilitated the characterisation of extra-cranial tumours. However, cell-free tumour DNA in plasma is limited in quantity and may not reliably capture the landscape of genomic alterations of brain tumours. Here, we review recent work assessing the relevance of cell-free tumour DNA from cerebrospinal fluid in the characterisation of brain cancer. We focus on the advances in the use of the cerebrospinal fluid as a source of cell-free tumour DNA to facilitate diagnosis, reveal actionable genomic alterations, monitor responses to therapy, and capture tumour heterogeneity in patients with primary brain tumours and brain and leptomeningeal metastases. Profiling cerebrospinal fluid cell-free tumour DNA provides the opportunity to precisely acquire and monitor genomic information in real time and guide precision therapies.
Fichier principal
Vignette du fichier
1-s2.0-S0923753419310397-main.pdf (291.69 Ko) Télécharger le fichier
Loading...

Dates et versions

inserm-02941510 , version 1 (17-09-2020)

Identifiants

Citer

J. Seoane, L. de Mattos-Arruda, E. Le Rhun, A. Bardelli, M. Weller. Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases. Annals of Oncology, 2019, 30 (2), pp.211-218. ⟨10.1093/annonc/mdy544⟩. ⟨inserm-02941510⟩

Collections

INSERM UNIV-LILLE
25 Consultations
77 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More